Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
WK Kellogg CoWK Kellogg Co Reports Mixed Financial Results for Quarter Ended September 28, 2024, Amid Restructuring Efforts
MetaVia Inc.NeuroBo Pharmaceuticals Reports Significant Changes in Revenue, Expenses, and Financial Health in Q3 2024
Gevo, Inc.Gevo Reports 57% Revenue Decline, Net Loss Increase in Q3 2024
CEDAR REALTY TRUST, INC.Cedar Realty Trust Reports Decline in Revenues and Profitability in Q3 2024
Eventbrite, Inc.Eventbrite Reports Mixed Q3 Results, Net Loss Narrows, Revenue Declines 5%
aTYR PHARMA INCaTyr Pharma Reports Significant Financial Challenges, No Revenue in Latest Quarter
APPLIED OPTOELECTRONICS, INC.Applied Optoelectronics Reports Mixed Q3 Results with Revenue Growth, Widening Losses
Yarrow Bioscience, Inc.VYNE Therapeutics Reports Modest Revenue Growth, Significant Increase in Operating Expenses and Losses in Q3 2024
HeartBeam, Inc.HeartBeam Reports Significant Financial Challenges, Decline in Cash and Cash Equivalents
Lantern Pharma Inc.Lantern Pharma Reports Significant Decline in Total Assets and Net Losses Amid Rising Operating Expenses
RIGEL PHARMACEUTICALS INCRigel Pharmaceuticals Reports Significant Revenue Growth and Profitability Improvement in Q3 2024
ALX ONCOLOGY HOLDINGS INCALX Oncology Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Latest 10-Q Filing
Goldman Sachs Physical Gold ETFGoldman Sachs Physical Gold ETF Reports Significant Growth in Q3 2024
ARKO Corp.ARKO Corp. Reports Decline in Revenue and Profitability for Q3 and Nine Months of 2024
Intapp, Inc.Intapp Reports 17% Revenue Growth, Improved Operating Performance in Q3 2024
COLLEGIUM PHARMACEUTICAL, INCCollegium Pharmaceutical Reports 16.5% Revenue Growth, Net Income Decline in Q3 2024
NI Holdings, Inc.Ni Holdings Reports Revenue Growth, Net Loss in Q3 2024 Amid Strategic Changes
Diamondback Energy, Inc.Diamondback Energy Reports Revenue Growth, Strategic Acquisitions, and Increased Debt in Q3 2024
Co-Diagnostics, Inc.Co-Diagnostics Reports Significant Financial Decline, Net Loss Widens in Q3 2024
Bunker Hill Mining Corp.Bunker Hill Mining Reports Significant Financial Challenges, Net Loss of $8.1 Million in Q3 2024
Claros Mortgage Trust, Inc.Claros Mortgage Trust Reports Decline in Revenues and Net Income Amid Challenging Market Conditions
DT Cloud Acquisition CorpDT Cloud Acquisition Corporation Reports Significant Financial Changes, Net Income Recovery in Latest 10-Q Filing
RELMADA THERAPEUTICS, INC.Relmada Therapeutics Reports Significant Financial Decline, Net Loss in Q3 2024
SUPERIOR INDUSTRIES INTERNATIONAL INCSuperior Industries Reports Mixed Q3 Results Amid Challenging Market Conditions
Intellia Therapeutics, Inc.Intellia Therapeutics Reports Financial Challenges, Decrease in Cash Reserves, and Increased Research and Development Expenses